Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,167Revenue (TTM) $M334Net Margin (%)-1.5Altman Z-Score16.4
Enterprise Value $M1,057EPS (TTM) $-0.1Operating Margin %-2.2Piotroski F-Score7
P/E(ttm)--Beneish M-Score-2.0Pre-tax Margin (%)-0.9Higher ROA y-yY
Price/Book6.810-y EBITDA Growth Rate %--Quick Ratio4.0Cash flow > EarningsY
Price/Sales3.45-y EBITDA Growth Rate %--Current Ratio4.0Lower Leverage y-yY
Price/Free Cash Flow468y-y EBITDA Growth Rate %--ROA % (ttm)-2.5Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-3.3Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M34.7ROIC % (ttm)8.0Gross Margin Increase y-yY

Gurus Latest Trades with GHDX

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

GHDX is held by these investors:



GHDX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Cole G BradleyCOO 2017-10-10Sell5,000$31.935.51view
Popovits Kimberly JPresident and CEO 2017-09-14Sell5,000$318.68view
Cole G BradleyCOO 2017-09-12Sell5,000$31.865.74view
Popovits Kimberly JPresident and CEO 2017-08-14Sell5,000$30.2211.48view
Vaughn James JChief Commercial Officer 2017-08-08Sell8,000$30.5910.13view
Cole G BradleyCOO 2017-08-08Sell5,000$30.5710.21view
Febbo Phillip G.Chief Medical Officer 2017-07-19Sell3,174$33.570.36view
Cole G BradleyCOO 2017-07-11Sell5,000$32.533.57view
Popovits Kimberly JPresident and CEO 2017-07-05Sell5,000$32.593.38view
Shak StevenChief Scientific Officer 2017-06-23Sell5,000$33.271.26view

Quarterly/Annual Reports about GHDX:

News about GHDX:

Articles On GuruFocus.com
Genomic Health and Biocartis Announce Agreement to Develop an Idylla™ IVD Oncotype DX® Breast Can Sep 13 2017 
Genomic Health Presents Data Demonstrating Importance of Oncotype DX Breast Recurrence Score® Test Sep 11 2017 
Genomic Health Continues to Pioneer Genomic-based Cancer Diagnostics with Multiple Presentations at Aug 31 2017 
Genomic Health to Present at the 2017 Wells Fargo Healthcare Conference Aug 30 2017 
Medicare Establishes Final Local Coverage Determination (LCD) for Use of the Oncotype DX® Genomic P Aug 24 2017 
Genomic Health Announces Second Quarter 2017 Financial Results and Reports Recent Business Progress Aug 01 2017 
Genomic Health to Announce Second Quarter 2017 Financial Results and Host Conference Call on Tuesday Jul 20 2017 
Updated St. Gallen International Breast Cancer Guidelines Reinforce Important Role of Genomic Testin Jul 12 2017 
Genomic Health Presents Data Further Demonstrating Ability of Oncotype DX® Tests to Optimize Outcom Jun 02 2017 
Genomic Health Announces Presentation of Eight Oncotype DX® Studies at the 2017 American Society of May 30 2017 
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}
FEEDBACK